Concentrix (NASDAQ:CNXC) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen downgraded shares of Concentrix (NASDAQ:CNXC) from a buy rating to a hold rating in a research note issued to investors on Saturday morning.

A number of other equities research analysts have also recently issued reports on CNXC. Weiss Ratings raised Concentrix from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, January 8th. Robert W. Baird set a $52.00 price objective on shares of Concentrix in a research note on Wednesday. Barrington Research reiterated an “outperform” rating and issued a $62.00 target price on shares of Concentrix in a research note on Monday, January 12th. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $80.00 target price on shares of Concentrix in a report on Tuesday, September 23rd. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $63.75.

Concentrix Stock Up 2.3%

Concentrix stock opened at $43.15 on Friday. The company has a current ratio of 1.40, a quick ratio of 1.56 and a debt-to-equity ratio of 1.67. Concentrix has a 1-year low of $31.63 and a 1-year high of $66.00. The firm’s fifty day simple moving average is $38.78 and its 200-day simple moving average is $46.48. The company has a market capitalization of $2.69 billion, a P/E ratio of -2.07, a P/E/G ratio of 0.48 and a beta of 0.48.

Concentrix (NASDAQ:CNXC) last posted its earnings results on Tuesday, January 13th. The company reported $2.95 EPS for the quarter, topping the consensus estimate of $2.93 by $0.02. Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. The firm had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.54 billion. During the same period in the prior year, the business posted $3.26 earnings per share. The business’s quarterly revenue was up 4.3% on a year-over-year basis. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. Sell-side analysts forecast that Concentrix will post 10.11 earnings per share for the current fiscal year.

Concentrix Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, February 10th. Shareholders of record on Friday, January 30th will be issued a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend is Friday, January 30th. Concentrix’s payout ratio is -6.91%.

Insider Activity

In other Concentrix news, CEO Christopher A. Caldwell acquired 2,000 shares of Concentrix stock in a transaction dated Thursday, October 30th. The stock was bought at an average cost of $42.03 per share, with a total value of $84,060.00. Following the acquisition, the chief executive officer owned 286,661 shares of the company’s stock, valued at approximately $12,048,361.83. The trade was a 0.70% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On Concentrix

Several large investors have recently modified their holdings of CNXC. Royal Bank of Canada boosted its stake in Concentrix by 9.5% in the 1st quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after buying an additional 4,133 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in Concentrix by 75.1% during the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock worth $23,552,000 after acquiring an additional 181,546 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Concentrix by 17.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after acquiring an additional 21,746 shares during the period. Focus Partners Wealth bought a new position in shares of Concentrix during the first quarter valued at $781,000. Finally, Geneos Wealth Management Inc. boosted its stake in shares of Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares in the last quarter. 90.34% of the stock is currently owned by institutional investors.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.